References
- de JW, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunology 2009;10:52–62.
- Lindi R, Jo-Ann SP, Carolyn W, Francesca L, Lisa MB, Koleka M, Wendy AB, Francois VL, Gerhard W, Joel FDS, Quarraishi AK, Salim SAK. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 2010;24:819–31.
- John LF. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection. Clin Diagn Lab Immunol 1998;5:597–603.
- Tarrant JM. Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use. Toxicol Sci 2010;117:4–16.
- Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000; 12:1712–6.
- Niwa Y, Akamatsu H, Sumi H, Ozaki Y, Abe A. Evidence for degradation of cytokines in the serum of patients with atopic dermatitis by calcium-dependent protease. Arch Dermatol Res 2000;292:391–6.
- Wong HL, Pfeiffer RM, Fears TR, Vermeulen RJS, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008;17:3450–6.
- Hosnijeh FS, Krop EJ, Portenge L, Rabkin CS, Linseisen J, Vineis P, Vermeulen R. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers 2009;15:140–8.
- Fujita M, Ishihara M, Ono K, Hattori H, Kurita A, Shimizu M, Mitsumaru A, Segawa D, Hinokiyama K, Kusama Y, Kikuchi M, Maehara T. Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit. Artif Organs 2002;26:1020–5.
- Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002;41:391–412.
- Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992;153:115–24.
- Zimmermann R, Ringwald J, Eckstein R. EDTA plasma is unsuitable for in vivo determinations of platelet-derived angiogenic cytokines. J Immunol Method 2009;347: 91–102.
- White JG. EDTA-induced changes in platelet structure and function:clot retraction. Platelets 2000;11:49–55.
- Biancotto A, Feng X, Langweiler M, Young NS, McCoy JP. Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. Cytokine 2012; 60:438–46.
- Hoffmann JN, Hartl WH, Faist E, Jochum M, Inthorn D. Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes. Inflammat Res 1997;46:342–7.